flarin 200 mg kapsler, bløde
infirst healthcare limited - ibuprofen - kapsler, bløde - 200 mg
lodin 200 ec flydende middel
agrichem b. v. - fluroxypyr - flydende middel - 200 g/l fluroxypyr
reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - andre præparater antianemic - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
fentanyl "hameln" 50 mikrogram/ml injektionsvæske, opløsning
hameln pharma gmbh - fentanylcitrat - injektionsvæske, opløsning - 50 mikrogram/ml
nifedipin "alternova" 60 mg depottabletter
alternova a/s - nifedipin - depottabletter - 60 mg
pylobactell
torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - diagnostiske midler - dette lægemiddel er kun til diagnostisk brug. til in vivo-diagnosticering af gastroduodenal helicobacter pylori (h. pylori) infektion.
nifedipin "alternova" 30 mg depottabletter
alternova a/s - nifedipin - depottabletter - 30 mg
lumica suspensionskoncentrat
syngenta nordics a/s - mesotrion - suspensionskoncentrat - 100 g/l mesotrion
meristo suspensionskoncentrat
syngenta nordics a/s - mesotrion - suspensionskoncentrat - 100 g/l mesotrion
rydapt
novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - antineoplastiske midler - rydapt er anført:i kombination med standard daunorubicin og cytarabine induktion og høj dosis cytarabine konsolidering kemoterapi, og for patienter i komplet respons efterfulgt af rydapt enkelt agent vedligeholdelse terapi til voksne patienter med nyligt diagnosticeret med akut myeloid leukæmi (aml), der er flt3 positiv mutation (se afsnit 4. 2);som monoterapi til behandling af voksne patienter med aggressiv systemisk mastocytose (asm), systemisk mastocytose, der er forbundet med hæmatologiske neoplasi (sm ahn), eller mastcelle leukæmi (mcl).